Diabetes researchers challenge decades-old theory about Type 1 disease

A new letter in Diabetologia questions the dominant paradigm explaining Type 1 diabetes development and proposes an alternative hypothesis. The shift could reshape how pharmaceutical companies design prevention trials and how clinicians identify at-risk patients—potentially opening new treatment pathways for a disease affecting millions globally.

Originaltitel: The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes. Reply to Nerup J, Lernmark A [letter]